Literature DB >> 27619677

miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.

Qijue Lu1, Li Xu2, Chunguang Li1, Yang Yuan1, Shengdong Huang1, Hezhong Chen3,4.   

Abstract

Previous studies verified that miR-214 is of great significance in the invasion and migration of a variety of cancers. It has been demonstrated that UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7(GALNT7) is a putative target of miR-214. We performed this study to figure out how miR-214 and GALNT7 play their roles in the invasion and migration of esophageal squamous cell carcinoma (ESCC). The expression of miR-214 was significantly downregulated in tumors compared to the corresponding non-tumor tissues while GALNT7 showed an opposite tendency. The low expression of miR-214 and the high expression of GALNT7 were found positively correlated with poor tumor differentiation (P = 0.004), tumor invasion (P = 0.013), and lymph node metastasis (P = 0.012) in ESCC patients. Functional study demonstrated that overexpression of miR-214 or knockdown of GALNT7 could weaken invasive and migratory ability in Eca109, TE1, and KYSE150. Moreover, tumorigenicity assay showed us mice injected with cells containing miR-214 mimic or GALNT7 small interfering RNA formed substantially smaller tumors than that in miR-214 inhibitor group. Consequently, we concluded that miR-214 shows potential to be a diagnostic marker and therapeutic target in ESCC.

Entities:  

Keywords:  ESCC; GALNT7; Invasion; Migration; miR-214

Mesh:

Substances:

Year:  2016        PMID: 27619677     DOI: 10.1007/s13277-016-5320-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  21 in total

1.  Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma.

Authors:  Yi Zhou; Liu Hong
Journal:  Genet Test Mol Biomarkers       Date:  2013-05-13

2.  miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.

Authors:  Avital Gaziel-Sovran; Miguel F Segura; Raffaella Di Micco; Mary K Collins; Douglas Hanniford; Eleazar Vega-Saenz de Miera; John F Rakus; John F Dankert; Shulian Shang; Robert S Kerbel; Nina Bhardwaj; Yongzhao Shao; Farbod Darvishian; Jiri Zavadil; Adrian Erlebacher; Lara K Mahal; Iman Osman; Eva Hernando
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

3.  MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines.

Authors:  Yong-Sheng Wang; Yin-Hua Wang; Hong-Ping Xia; Song-Wen Zhou; Gerald Schmid-Bindert; Cai-Cun Zhou
Journal:  Asian Pac J Cancer Prev       Date:  2012

4.  microRNA-214 enhances the invasion ability of breast cancer cells by targeting p53.

Authors:  Fang Wang; Pengwei Lv; Xinwei Liu; Mingzhi Zhu; Xinguang Qiu
Journal:  Int J Mol Med       Date:  2015-03-03       Impact factor: 4.101

Review 5.  miR-214 as a key hub that controls cancer networks: small player, multiple functions.

Authors:  Elisa Penna; Francesca Orso; Daniela Taverna
Journal:  J Invest Dermatol       Date:  2014-12-11       Impact factor: 8.551

Review 6.  MicroRNAs and esophageal cancer--implications for pathogenesis and therapy.

Authors:  George C Mayne; Damian J Hussey; David I Watson
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 7.  MicroRNAome genome: a treasure for cancer diagnosis and therapy.

Authors:  Ioana Berindan-Neagoe; Paloma del C Monroig; Barbara Pasculli; George A Calin
Journal:  CA Cancer J Clin       Date:  2014-08-07       Impact factor: 508.702

8.  MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN.

Authors:  Ting-Song Yang; Xiao-Hu Yang; Xu-Dong Wang; Yi-Ling Wang; Bo Zhou; Zhen-Shun Song
Journal:  Cancer Cell Int       Date:  2013-07-08       Impact factor: 5.722

9.  Functional elucidation of miR-494 in the tumorigenesis of nasopharyngeal carcinoma.

Authors:  Hong-Fang Duan; Xiao-Qing Li; Hong-Yi Hu; Yu-Chi Li; Zhi Cai; Xue-Shuang Mei; Peng Yu; Li-Ping Nie; Wei Zhang; Zhen-Dong Yu; Guo-Hui Nie
Journal:  Tumour Biol       Date:  2015-03-26

10.  MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.

Authors:  Sheng-Dong Huang; Yang Yuan; Chong-Wen Zhuang; Bai-Ling Li; De-Jun Gong; Shu-Gang Wang; Zhi-Yong Zeng; He-Zhong Cheng
Journal:  Mol Cancer       Date:  2012-08-06       Impact factor: 27.401

View more
  15 in total

1.  Knockdown of differentiation antagonizing non-protein coding RNA exerts anti-tumor effect by up-regulating miR-214 in endometrial carcinoma.

Authors:  Jingli Sun; Shaofeng Gao; Cuihua Lu
Journal:  Mol Cell Biochem       Date:  2019-06-03       Impact factor: 3.396

2.  A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody.

Authors:  Catharina Steentoft; Max Fuhrmann; Federico Battisti; Julie Van Coillie; Thomas D Madsen; Diana Campos; Adnan Halim; Sergey Y Vakhrushev; Hiren J Joshi; Hans Schreiber; Ulla Mandel; Yoshiki Narimatsu
Journal:  Glycobiology       Date:  2019-04-01       Impact factor: 4.313

3.  Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate Cancer.

Authors:  Patrice Cagle; Nikia Smith; Timothy O Adekoya; Yahui Li; Susy Kim; Leslimar Rios-Colon; Gagan Deep; Suryakant Niture; Christopher Albanese; Simeng Suy; Sean P Collins; Deepak Kumar
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

4.  miR-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting CADM1.

Authors:  Haiqing Cai; Mingyuan Miao; Zhigang Wang
Journal:  Oncol Lett       Date:  2018-06-08       Impact factor: 2.967

5.  MicroRNA-30e Functions as a Tumor Suppressor in Cervical Carcinoma Cells through Targeting GALNT7.

Authors:  Huijuan Wu; Jun Chen; Dan Li; Xiangyu Liu; Lei Li; Ke Wang
Journal:  Transl Oncol       Date:  2017-09-27       Impact factor: 4.243

Review 6.  Epigenetic Bases of Aberrant Glycosylation in Cancer.

Authors:  Fabio Dall'Olio; Marco Trinchera
Journal:  Int J Mol Sci       Date:  2017-05-06       Impact factor: 5.923

7.  Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214.

Authors:  Po-Shuan Huang; Yang-Hsiang Lin; Hsiang-Cheng Chi; Pei-Yu Chen; Ya-Hui Huang; Chau-Ting Yeh; Chia-Siu Wang; Kwang-Huei Lin
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

8.  High expression of GALNT7 promotes invasion and proliferation of glioma cells.

Authors:  Shi Hua; Hongyan Li; Yuguang Liu; Jian Zhang; Yanhao Cheng; Chao Dai
Journal:  Oncol Lett       Date:  2018-09-25       Impact factor: 2.967

9.  Effects of microRNA-136 on melanoma cell proliferation, apoptosis, and epithelial-mesenchymal transition by targetting PMEL through the Wnt signaling pathway.

Authors:  Jiu-Jiang Wang; Zhi-Feng Li; Xiao-Jing Li; Zhao Han; Ling Zhang; Zhi-Jun Liu
Journal:  Biosci Rep       Date:  2017-09-07       Impact factor: 3.840

10.  microRNA-214 suppresses the growth of cervical cancer cells by targeting EZH2.

Authors:  Yanling Yang; Yang Liu; Guilin Li; Lei Li; Peng Geng; Hongjuan Song
Journal:  Oncol Lett       Date:  2018-08-24       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.